Aldeyra Therapeutics, Inc. (ALDX) Class Action Lawsuit (July 2023)

Closed

1:23cv11737 • July 31, 2023

Class Period Start

January 7, 2021

Class Period End

October 16, 2023

PSLRA Deadline

September 29, 2023

Case Allegations

10b5

Statutes of Repose

Jan 7, 2024

Country

United States

Court

Federal Court

Docket History

Mar 14, 2025

Motion to Dismiss Granted (opens in a new tab)

The court has granted the defendants' request to dismiss the lawsuit. Depending on the court's decision, the plaintiffs may be allowed to file an updated complaint or pursue an appeal.

Mar 4, 2024

Motion to Dismiss (opens in a new tab)

After reviewing the complaint(s) filed by plaintiffs, defendants have filed a motion requesting that the court dismiss some or all of the plaintiffs' claims. In a motion to dismiss, defendants might challenge the validity of plaintiffs' claims or adequacy of plaintiffs' pleadings. Once a motion to dismiss is filed, the judge will make a decision on whether part or all of the case should be dismissed or the case can proceed as alleged.

Jan 2, 2024

First Amended Complaint (opens in a new tab)

A new complaint has been filed on behalf of certain investors in Aldeyra Therapeutics, Inc.. Amended complaints may contain additional facts, parties, allegations, a change in the class definition, etc.

Nov 1, 2023

Appointment of Lead Plaintiff (opens in a new tab)

The court has appointed a lead plaintiff to represent the interests of investors in the lawsuit. The lead plaintiff works with the attorneys handling the case, helps oversee the litigation, and represents the interests of the proposed class.

Jul 31, 2023

First Filed Complaint (opens in a new tab)

A securities fraud class action complaint has been filed on behalf of certain investors in Aldeyra Therapeutics, Inc..